New research study for Type 1 Diabetes patients where their current long-acting insulin will be replaced by a once-weekly study insulin or approved daily long-acting insulin.
Please fill in your details
About the Study
This study is for patients with Type 1 Diabetes who are not currently using an insulin pump. Patients will have their current long-acting insulin replaced by either a once-weekly study insulin or an approved daily long-acting insulin, Tresiba. The weekly long-acting study insulin can help reduce the number of shots patients have to take each day.
Study participants will receive study-related care and study medication/supplies at no charge. You may also receive compensation for travel expenses
To take part in the study, participants should be:
- Adults with Type 1 Diabetes
- A1C 7.0 and 10.0%
- Not using an insulin pump